| 6.86 -0.4 (-5.51%) | 10-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.6 | 1-year : | 10.04 |
| Resists | First : | 7.36 | Second : | 8.6 |
| Pivot price | 6.73  |
|||
| Supports | First : | 6.06 |
Second : | 5.26 |
| MAs | MA(5) : | 7.11 |
MA(20) : | 6.53 |
| MA(100) : | 6.1 |
MA(250) : | 6.36 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 83.6 |
D(3) : | 91.2 |
| RSI | RSI(14): 61.6 |
|||
| 52-week | High : | 8.28 | Low : | 5.04 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ INGN ] has closed below upper band by 41.9%. Bollinger Bands are 72.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 7.3 - 7.34 | 7.34 - 7.37 |
| Low: | 6.6 - 6.64 | 6.64 - 6.66 |
| Close: | 6.8 - 6.86 | 6.86 - 6.91 |
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Tue, 20 Oct 2026
Inogen: Cheap Enough To Take A Chance On - Seeking Alpha
Thu, 15 Oct 2026
Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026 - Business Wire
Wed, 30 Sep 2026
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech - Business Wire
Wed, 30 Sep 2026
Inogen (INGN) Sells U.S. Oxygen Rental Business to Rotech Health - GuruFocus
Fri, 21 Aug 2026
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Yahoo Finance
Mon, 17 Aug 2026
Inogen (INGN) Cuts Guidance Even As Profitability Climbs - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 27 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 12.9 (%) |
| Held by Institutions | 80.1 (%) |
| Shares Short | 1,470 (K) |
| Shares Short P.Month | 1,460 (K) |
| EPS | -0.93 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.53 |
| Profit Margin | -7 % |
| Operating Margin | -5.2 % |
| Return on Assets (ttm) | -5.9 % |
| Return on Equity (ttm) | -13.2 % |
| Qtrly Rev. Growth | 3 % |
| Gross Profit (p.s.) | 5.94 |
| Sales Per Share | 13.34 |
| EBITDA (p.s.) | -0.31 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -7.46 |
| PEG Ratio | 0 |
| Price to Book value | 1.04 |
| Price to Sales | 0.51 |
| Price to Cash Flow | -72.25 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|